Both tirzepatide and semaglutide were associated with increased risk of gastrointestinal adverse events compared with placebo at all doses, tirzepatide 15mg was associated with the highest risk for nausea (3.6 times), vomiting (4.4 times) and diarrhoea (2.0 times)
Lo mejor es cambiar el estilo de vida: Funciona junto con la dieta y el ejercicio, no como una solucin independiente
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Keto reduces insulin demand through macronutrient restriction
The medications positive impact on cardiovascular health and glycemic control sets it apart from other weight loss methods